Allschwil, Switzerland

Stefan Reber

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Reber

Introduction

Stefan Reber is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline forms of various compounds. With a total of 3 patents to his name, Reber's work has the potential to impact medical treatments significantly.

Latest Patents

Reber's latest patents focus on crystalline forms of a specific compound, 4-((R)-2-{[6-((S)-3-methoxy-pyrrolidin-1-yl)-2-phenyl-pyrimidine-4-carbonyl]-amino}-3-phosphono-propionyl)-piperazine-1-carboxylic acid butyl ester hydrochloride. These inventions include processes for the preparation of these crystalline forms, pharmaceutical compositions that comprise them, and their use as a medicament, particularly as a P2Y receptor antagonist. This innovative work showcases his dedication to advancing pharmaceutical science.

Career Highlights

Throughout his career, Stefan Reber has worked with prominent companies in the pharmaceutical industry. He has been associated with Idorsia Pharmaceuticals Ltd and Viatris Asia Pacific Ptd. Ltd. His experience in these organizations has allowed him to hone his skills and contribute to significant advancements in drug development.

Collaborations

Reber has collaborated with several professionals in his field, including Daniel Leuenberger and Markus Von Raumer. These collaborations have likely enriched his work and fostered innovation in his projects.

Conclusion

Stefan Reber's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…